Search results
Study at Japan's Kameda Medical Center Demonstrates Excellent Outcomes for Ibex's AI-powered...
FOX 59 Indianapolis· 6 days agoIbex Medical Analytics (Ibex), a global leader in AI-powered cancer diagnostics, and Kameda Medical...
Iran's president dies in helicopter crash; Michael Cohen's cross-examination wraps up
NPR· 6 days agoIn most of the world, they are considered cosmetics. Companies can be wary of the FDA process...
New mechanisms underlying tumor variety in brain cancers discovered
Medical Xpress· 6 days agoInvestigators have discovered new mechanisms underlying the diversity of characteristics within a...
FTC Oversight of Pharmaceutical Sector 'Minimal' Over Last 20-Plus Years
MedPage Today· 6 days agoThe Federal Trade Commission (FTC) pursued about one merger action and three enforcement actions per...
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid...
Digital Journal· 6 days agoBuloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment. The data were orally presented at the ATS International Congress and will be reviewed ...
Add-On Dupilumab for COPD Backed by Second Phase III Trial
MedPage Today· 5 days agoAdding dupilumab (Dupixent) to triple therapy reduced exacerbations and improved lung function for...
GLP-1 Agonist Scripts Jumped 600% for Teens, Young Adults Since 2020
MedPage Today· 4 days agoThe number of adolescents and young adults prescribed a glucagon-like peptide-1 (GLP-1) receptor...
Heidi Edwards lost her family to this rare genetic disease. Now she's fighting back
Lebanon Daily News via Yahoo News· 6 days agoIn one case, a treatment for the disease is showing promising results and is currently in a phase...
All Over the Map? Mechanisms of ICI Acquired Resistance in NSCLC
MedPage Today· 2 days ago"Resistance is futile." What's less debatable, though, is that patients with non-small cell lung...
Novel Drugs for IPF Improve Lung Function in Mid-Stage Trials
MedPage Today· 6 days ago'These are among the two most exciting sets of results we've seen,' researcher says